SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

DaVitas warning that Medicare reimbursement for CorMedixs DefenCath could fall sharply in 2027 has fueled a steep selloff and concern about future pricing and sales. Traders dispute how conclusive DaVitas estimate is, pointing to CMSs finalized payment rate and arguing the outlook depends on quarterly calculations and DefenCath uptake.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

FDA approval of Inovios competing RRP treatment has put Precigens PAPZIMEOS under scrutiny, with traders debating whether the new option will erode its market position. Some fear stronger competition, while others point to Precigens first-mover and full-approval advantages and question Inovios ability to commercialize its drug.

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Regeneron Pharmaceuticals, Inc.

Regenerons stronger-than-expected third-quarter results, supported by Eylea HD and Dupixent-related collaboration revenue, are driving a sharp breakout to multiyear highs. Traders are broadly bullish on the results and follow-through, while some question whether the gains will hold.

Transocean Ltd. engages in the provision of offshore contract drilling services for oil and gas wells. It also owns and operates offshore drilling fleets such as ultra-deepwater, harsh environment, deepwater, and midwater rigs. The company was founded in 1953 and is headquartered in Steinhausen, Switzerland.

Transocean Ltd

Transocean is drawing attention after Brazil approved its Valaris merger, which traders see as a step toward closing the deal, alongside recent offshore contract wins and higher day-rate expectations. Bulls anticipate improved scale and a potential short squeeze, while skeptics point to merger-related dilution, debt and the upcoming earnings report.

Shopify, Inc. is a global commerce company that provides essential internet infrastructure for commerce, offering trusted tools to start, scale, market, and run a retail business of any size. The Company's software enables merchants to run their business across all of their sales channels, including web and mobile storefronts, physical retail locations, social media storefronts and marketplaces. The Shopify platform provides merchants with a single view of their business across all of their sales channels and enables them to manage products and inventory, process orders and payments, fulfill and ship orders, build customer relationships, source products, leverage analytics and reporting and access financing, all from one integrated back office. The company was founded on September 28, 2004 and is headquartered in Ottawa, Canada.

Shopify Inc - Ordinary Shares - Class A (Sub Voting)

Shopify Inc

Shopifys integration with Metas Muse AI agent, which can route purchases through Shop Pay, has fueled discussion about whether agentic commerce will expand Shopifys role in online shopping or threaten traditional storefronts. Traders are also debating the stocks sharp, volatile pullback, with some looking ahead to earnings and others concerned about valuation and whether AI-related growth will translate into revenue.

Zcash (ZEC) is a cryptocurrency . Users are able to generate ZEC through the process of mining. Zcash has a current supply of 16,942,077.7905448. The last known price of Zcash is 1,263.32437248 USD and is up 2.82 over the last 24 hours. It is currently trading on 668 active market(s) with $1,115,981,976.30 traded over the last 24 hours. More information can be found at https://z.cash/.

Zcash

Zcashs sharp rebound and resilience amid broader crypto weakness and Binance hack fears have traders highlighting its privacy features and speculating about a safe-haven shift into ZEC; some also point to the upcoming NU7 upgrade. Others view the rally as overextended and expect further declines.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

A stronger-than-expected quarterly report and higher full-year revenue outlook, powered by demand for Mounjaro and Zepbound, have fueled LLYs rally and record highs. Traders are largely positive and cite analyst upgrades, while some question the valuation and point to trimmed profit guidance tied to acquisition-related research charges.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

A rally to a fresh 52-week high ahead of an expected quarterly report has traders focused on BRIUMVI growth and whether results can justify the run; some expect an earnings-driven move, while others warn the stock may be priced for a beat. Buyout speculation and possible short covering are also fueling bullish chatter, but no deal is confirmed and the earnings timing remains uncertain.

BankrCoin (BNKR) is a cryptocurrency and operates on the Base platform. BankrCoin has a current supply of 100,000,000,000 with 99,389,999,999.99966667 in circulation. The last known price of BankrCoin is 0.00029512 USD and is up 9.48 over the last 24 hours. It is currently trading on 84 active market(s) with $2,292,823.67 traded over the last 24 hours. More information can be found at https://warpcast.com/bankr.

BankrCoin

Traders are focused on Bankrs expanding AI-agent infrastructure and ecosystem integrations, alongside claims of protocol revenue, staking rewards and token buybacks that could support BNKR demand. Sentiment is largely bullish and accumulation-oriented, though some traders question whether the sharp moves are sustainable or speculative.

ExxonMobil Holdings Corp. is an international energy and petrochemical company, which creates solutions that improve quality of life and meets society’s evolving needs. The company is headquartered in Spring, TX.

ExxonMobil Holdings Corp.

Exxon Mobil Corp

Exxons quarterly results beat expectations, with record refining performance benefiting from tight diesel supplies amid geopolitical disruptions. Traders are broadly positive on the refining-led strength and shareholder returns, while some question whether the unusually strong margins can last.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

LMND Stock Rises Pre-Market: Morgan Stanley Backs Its Early Bet On Autonomous Vehicle Insurance

Equity

Morgan Stanley said Lemonade’s initial move into the self-driving vehicle space “represents an important first step.”

Are Tech ETFs New Safe Haven Amid Iran War?

Iran war volatility lifts oil and rattles stocks. But tech ETFs, powered by AI, cloud and cybersecurity demand, are emerging as surprising defensive plays.

Lemonade Stock Jumps Pre-Market As Morgan Stanley Upgrades On Growth Optimism: Retail Rides Along 

The brokerage praised the company’s “differentiated” AI-driven technology and its roadmap to achieve net profit positivity by the end of 2027.


Amplify ETF Trust - Amplify BlueStar Israel Technology ETF

Neutral Sentiment

<ul class="summary-bullets"><li>Morgan Stanley increased the price target for Lemonade to $85 from $80.&nbsp;</li><li>Tesla’s partnership puts the insurer ahead of competitors, Morgan Stanley says.&nbsp;</li><li>The firm indicated that pricing remains grounded in risk evaluation, suggesting a disciplined approach.</li></ul>Morgan Stanley has upgraded Lemonade Inc. (LMND) to an ‘Overweight’ rating, citing its emerging collaboration with Tesla Inc. (TSLA) as a catalyst that could reshape its long-term growth outlook.In January, the insurance provider introduced a new product for autonomous cars, initially targeting vehicles equipped with Tesla’s Full Self-Driving technology. (FSD)<a href="https://stocktwits.com/symbol/LMND">Lemonade stock</a> traded over 6% higher in Tuesday’s premarket. On Stocktwits, retail sentiment around the stock changed to ‘neutral’ from ‘bearish’ territory the previous day. Message volume shifted to ‘low’ from ‘extremely low’ message volume levels.&nbsp;<figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2025_08_18_092502_png_4d549e99e9.webp" alt="LMND’s Sentiment Meter and Message Volume as of 06:00 a.m. ET on Mar. 17, 2026 | Source: Stocktwits" width="947" height="108"><figcaption>LMND’s Sentiment Meter and Message Volume as of 06:00 a.m. ET on Mar. 17, 2026 | Source: Stocktwits</figcaption></figure><h2 class="st-heading-2">A First Mover Bet On Autonomous Insurance&nbsp;</h2>Morgan Stanley stated that Lemonade’s early involvement in the autonomous vehicle ecosystem "represents an important first step", according to TheFly. By working alongside Tesla, the insurer gains access to real-world driving data and operational insights, positioning it ahead of competitors in a space that is still developing.&nbsp;The firm sees this as a foundational move that could unlock future opportunities as self-driving adoption expands. Morgan Stanley also increased the price target for Lemonade to $85 from $80.&nbsp;<h2 class="st-heading-2">What Does It Mean For LMND’s Earnings Story?</h2>Lemonade has introduced a pricing incentive, offering a steep 50% discount on auto coverage when Tesla’s full self-driving mode is activated. Lemonade said drivers using the feature could see per-mile costs reduced by roughly half, reflecting internal data suggesting lower accident risk during automated operation.Despite this aggressive approach, Morgan Stanley noted that the company is not compromising on underwriting standards. The firm indicated that pricing remains grounded in risk evaluation, suggesting a disciplined approach even as it experiments with new models.Analysts expect Lemonade to deepen its exposure to autonomous driving over time, which could help scale its insurance platform. Morgan Stanley also believes this trajectory could “meaningfully improve” the company’s earnings profile over the longer term.LMND stock has declined over 18% year-to-date.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/lululemon-heads-for-first-sales-drop-in-six-years-amid-leadership-turmoil/cZ33yCfRIQ8">Lululemon Heads For First Sales Drop In Six Years Amid Leadership Turmoil</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the logo of Lemonade, Inc. is displayed on a smartphone screen, with the company's bright pink branding visible in the background, on May 04, 2025, in Chongqing, China.

Amplify Bluestar Israel Technology ETF

Lemonade Inc

Invesco Dorsey Wright Financial Momentum ETF

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Fundamentals

Info

ITEQ Amplify Bluestar Israel Technology ETF

Fundamentals

Latest ITEQ News